Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis.
J Bone Miner Res
; 24(4): 578-88, 2009 Apr.
Article
in En
| MEDLINE
| ID: mdl-19049336
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Osteogenesis
/
Bone and Bones
/
Genetic Markers
/
Osteoporosis, Postmenopausal
/
Bone Morphogenetic Proteins
/
Antibodies, Monoclonal
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
J Bone Miner Res
Journal subject:
METABOLISMO
/
ORTOPEDIA
Year:
2009
Type:
Article
Affiliation country:
United States